This week in drug discovery (15-19 August)

News round-up by DDW Editor Reece Armstrong for 15-19 August.

Covid booster approvals, positive results for Malaria vaccines and new CEOs are some of the stories in this week’s news round-up. 

MHRA approves Moderna’s bivalent Covid booster  

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved an updated version of Moderna’s Covid-19 booster vaccine that targets two coronavirus variants.

Positive results for US Malaria vaccine, trial shows 

A monoclonal antibody (mAb) treatment for the prevention of Malaria has shown encouraging results in a US Phase I clinical trial.

Sanofi signs $20m research agreement with Atomwise

Artificial intelligence (AI) company Atomwise has signed an exclusive research collaboration with Sanofi to use its AtomNet platform for computational discovery and research of up to five drug targets.

EMA approves early-stage breast cancer treatment  

A precision medicine for early-stage breast cancer has been approved by the European Medicines Agency (EMA).

Respira appoints new CEO to drive inhalable therapeutics

Clinical-stage company Respira Technologies has appointed a new Chief Executive Officer (CEO) to the company.

Related Articles

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free